Spyre Therapeutics, Inc.
SYRE
35 insider filings · Latest: Oct 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Oct 3 1:30 AM | Heidy King-JonesChief Legal Officer and Corporate Secretary | Sale | 28,933 | $91.03 | $2.6M | 2,845(D) | View → |
| Oct 1, 2026 | Oct 3 1:29 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $92.01 | $1.4M | 537,540(D) | View → |
| Oct 1, 2026 | Oct 3 1:29 AM | Scott L BurrowsChief Financial Officer | Sale | 7,500 | $91.83 | $688.8K | 79,762(D) | View → |
| Sep 30, 2026 | Oct 3 1:29 AM | Scott L BurrowsChief Financial Officer | Sale | 17,500 | $89.89 | $1.6M | 79,762(D) | View → |
| Oct 1, 2026 | Oct 1 8:36 PM | CAMERON TURTLE | Proposed Sale | 45,000 | $89.03 | $4.0M | — | View → |
| Oct 1, 2026 | Oct 1 8:30 PM | HEIDY KING-JONES | Proposed Sale | 29,335 | $89.03 | $2.6M | — | View → |
| Sep 30, 2026 | Sep 30 8:03 PM | SCOTT BURROWS | Proposed Sale | 17,500 | $89.89 | $1.6M | — | View → |
| Sep 2, 2026 | Sep 4 1:34 AM | Heidy King-JonesOfficer | Sale | 400 | $90.00 | $36.0K | 2,845(D) | View → |
| Sep 1, 2026 | Sep 4 1:34 AM | Heidy King-JonesOfficer | Sale | 27,999 | $87.31 | $2.4M | 2,845(D) | View → |
| Sep 2, 2026 | Sep 4 1:33 AM | Scott L BurrowsChief Financial Officer | Sale | 18,232 | $89.35 | $1.6M | 79,762(D) | View → |
| Sep 1, 2026 | Sep 4 1:33 AM | Scott L BurrowsChief Financial Officer | Sale | 7,500 | $87.31 | $654.8K | 97,994(D) | View → |
| Sep 1, 2026 | Sep 4 1:33 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $87.29 | $1.3M | 552,540(D) | View → |
| Sep 1, 2026 | Sep 1 8:57 PM | HEIDY KING-JONES | Proposed Sale | 46,665 | $89.33 | $4.2M | — | View → |
| Aug 7, 2026 | Aug 11 1:31 AM | Jeffrey W. AlbersDirector | Sale | 23,000 | $104.53 | $2.4M | 9,360(I) | View → |
| Aug 7, 2026 | Aug 7 8:39 PM | JEFFREY ALBERS | Proposed Sale | 5,000 | $103.42 | $517.1K | — | View → |
| Aug 7, 2026 | Aug 7 8:39 PM | SESSIONS, LLC | Proposed Sale | 18,000 | $103.42 | $1.9M | — | View → |
| Aug 3, 2026 | Aug 6 1:32 AM | Scott L BurrowsChief Financial Officer | Sale | 7,500 | $95.57 | $716.8K | 97,994(D) | View → |
| Aug 3, 2026 | Aug 6 1:31 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $95.51 | $1.4M | 567,540(D) | View → |
| Aug 3, 2026 | Aug 3 8:51 PM | SCOTT BURROWS | Proposed Sale | 30,000 | $98.33 | $2.9M | — | View → |
| Jul 1, 2026 | Jul 3 1:33 AM | Scott L BurrowsChief Financial Officer | Sale | 7,500 | $87.74 | $658.0K | 97,994(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 2 1:35 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 12,500 | $14.50 | 382,357(D) | View → |
| May 1, 2026 | May 2 1:34 AM | Sheldon SloanChief Medical Officer | Option Exercise | 78,333 | $27.46 | 321,667(D) | View → |
| Apr 1, 2026 | Apr 4 1:30 AM | Sheldon SloanChief Medical Officer | Option Exercise | 7,958 | $21.66 | 87,542(D) | View → |
| Apr 1, 2026 | Apr 4 1:29 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 7,500 | $14.50 | 394,857(D) | View → |
| Mar 3, 2026 | Mar 4 2:32 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 2,500 | $14.50 | 402,357(D) | View → |
← Previous
Page 2 of 2